www.fdanews.com/articles/83286-caraco-receives-final-approval-to-market-generic-ultracet
CARACO RECEIVES FINAL APPROVAL TO MARKET GENERIC ULTRACET
December 20, 2005
Caraco Pharmaceutical Laboratories has received final FDA approval for its abbreviated new drug application for tramadol HCl with acetaminophen in tablet form. Caraco's product is the generic equivalent of Ortho McNeil Pharmaceutical's Ultracet, which is indicated for the short-term management of acute pain.